07:00 , Aug 22, 2016 |  BC Week In Review  |  Company News

Protagen, Werfen deal

Protagen granted Werfen’s Inova Diagnostics Inc. company semi-exclusive rights to develop and commercialize biomarker bicaudal D homolog 2 (BICD2) , which Inova will add to its assay portfolio. The companies declined to disclose additional details....
07:00 , Jun 20, 2016 |  BC Week In Review  |  Company News

Protagen sales and marketing update

Protagen launched its Multilisa CENP-B, Multilisa Scl-70 and Multilisa BICD2 ELISA assays to diagnose systemic sclerosis. Multilisa CENP-B and Multilisa Scl-70 provide qualitative determination of IgG anti-centromer B and IgG anti-Scl-70 autoantibodies, respectively, in human...
07:00 , Sep 1, 2014 |  BC Week In Review  |  Company News

Protagen sales and marketing update

Protagen launched ADx SSc Multilisa in the EU and North America to research scleroderma. The qualitative ELISA-based test kit uses Protagen’s SeroTag biomarker platform to detect autoantibody levels of topoisomerase I (TOP1) , centromere protein...